NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/22/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization26.24 mln
Float27.37 mln
Earnings Date08/12/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
5.25
Highly suspicious
Relative Strength
41
/ 100
Slightly lagging
Debt / Equity
-12.39
Negative equity
ROE
-953
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Dyadic International is a US-based biotechnology company that develops and sells industrial enzymes and biological products for use in pharmaceuticals, food and nutrition, and industrial markets worldwide. Its core technology is the C1 platform, a protein production system that enables fast, large-scale manufacturing of biologics at competitive costs. The company is advancing a COVID-19 vaccine candidate through clinical trials and maintains active partnerships with research institutions and biotech firms across Europe, Africa, and beyond. Founded in 1979, Dyadic is headquartered in Jupiter, Florida.
